BARLOWORLD LIMITED - Allocation of forfeitable shares

Allocation of forfeitable shares

Barloworld Limited
(Incorporated in the Republic of South Africa)
(Registration number 1918/000095/06)
(Income Tax Registration number 9000/051/71/5)
(Share code: BAW)
(JSE ISIN: ZAE000026639)
(Share code: BAWP)
(JSE ISIN: ZAE000026647)
(Bond issuer code: BIBAW)
("Barloworld” or “the Company")

ALLOCATION OF FORFEITABLE SHARES

In accordance with paragraph 3.63 of the JSE Listings Requirements,
shareholders are advised that the following executive director and
prescribed officers of Barloworld, were awarded shares in terms of the
Company’s forfeitable share plan (all off market) on 25 November 2022,
the salient details of which are set out below:

Executive Director and Prescribed Officers of Barloworld:

Name of executive director:                   Dominic Sewela
Name of company:                              Barloworld
Designation:                                  Chief Executive Officer
Number of forfeitable shares awarded:         66 400 Barloworld ordinary
                                              shares
Consideration:                                Nil
Average price at which shares were awarded:   R108.1637
Vesting period:                               Three years from award
                                              date
Value:                                        R7 182 069.68
Acceptance date:                              12 December 2022
Nature of transaction:                        Direct beneficial interest


Name of Prescribed Officer:                   Emmy Leeka
Name of company:                              Barloworld
Designation:                                  Prescribed Officer
Number of forfeitable shares awarded:         27 850 Barloworld ordinary
                                              shares
Consideration                                 Nil
Average price at which shares were awarded:   R108.1637
Vesting period:                               Three years from award
                                              date
Value:                                        R3 012 359.05
Acceptance date:                              12 December 2022
Nature of transaction:                        Direct beneficial interest


Name of Prescribed Officer:                   Chris Wierenga
Name of company:                              Barloworld
Designation:                                  Prescribed Officer
Number of forfeitable shares awarded:         23 880 Barloworld ordinary
                                              shares
Consideration                                 Nil
Average price at which shares were awarded:   R108.1637
Vesting period:                               Three years from award
                                              date
Value:                                        R2 582 949.16
Acceptance date:                              13 December 2022
Nature of transaction:                        Direct beneficial interest

Approximately 100% of the shares awarded to the Chief Executive Officer
and Prescribed Officers of Barloworld are subject to performance
conditions. The performance conditions include performance targets for
improvement in Return on Invested Capital (ROIC), Free Cash Flow (FCF)
and growth in Headline Earnings Per Share (HEPS).

The necessary clearance in terms of paragraph 3.66 of the JSE Listings
Requirements has been obtained.

Barloworld shareholders approved the forfeitable share plan ("FSP") at
the Company`s annual general meeting on 28 January 2010. The FSP is
designed to align the objectives of Barloworld senior management with
the interests of shareholders.

The allocation of forfeitable shares was determined by the Barloworld
remuneration committee on a market related basis.




Sandton
13 December 2022

Sponsor: Nedbank Corporate and Investment Banking, a division of Nedbank
Limited

Date: 13-12-2022 04:45:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.